TY - CHAP
T1 - Deep Learning and Machine Learning Algorithms
T2 - A Blood-Brain Barrier Permeability Prediction Model with Accuracy
AU - Ahluwalia, Arjun
AU - Awuah, Wireko Andrew
AU - Shah, Muhammad Hamza
AU - Sanker, Vivek
AU - Darko, Kwadwo
AU - Ben-Jaafar, Adam
AU - Tan, Joecelyn Kirani
AU - Ranganathan, Sruthi
AU - Pearl, Tenkorang Ohenewaa
AU - Aderinto, Nicholas
AU - Abdul-Rahman, Toufik
AU - Atallah, Oday
AU - Alexiou, Athanasios
AU - Ashraf, Ghulam Md
N1 - Publisher Copyright:
© The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature 2025.
PY - 2025
Y1 - 2025
N2 - The blood-brain barrier (BBB) is an essential physiological separator that controls substance movement into the central nervous system (CNS) and is crucial for CNS stability. However, the neuroprotective role of the BBB, especially in disease states, presents significant challenges for brain drug delivery. This is evident in conditions with overactive efflux transporters, which prevent drugs from reaching target brain tissues or achieving effective concentrations. These complexities have led to a rise in utilizing a variety of deep learning (DL) models, including the employment of neural network models and support vector machines to predict drug permeability across the BBB and develop personalized care for CNS disorders. Furthermore, the high specificity and accuracy of these models, along with their increased efficiency, make them more favorable than traditional models as well as machine learning. However, the complexity of DL models, data imbalances, and the opaque nature of these algorithms present ongoing challenges. Despite these challenges, DL models have the potential to truly innovate the sphere of personalized medicine, especially in terms of neurological therapies.
AB - The blood-brain barrier (BBB) is an essential physiological separator that controls substance movement into the central nervous system (CNS) and is crucial for CNS stability. However, the neuroprotective role of the BBB, especially in disease states, presents significant challenges for brain drug delivery. This is evident in conditions with overactive efflux transporters, which prevent drugs from reaching target brain tissues or achieving effective concentrations. These complexities have led to a rise in utilizing a variety of deep learning (DL) models, including the employment of neural network models and support vector machines to predict drug permeability across the BBB and develop personalized care for CNS disorders. Furthermore, the high specificity and accuracy of these models, along with their increased efficiency, make them more favorable than traditional models as well as machine learning. However, the complexity of DL models, data imbalances, and the opaque nature of these algorithms present ongoing challenges. Despite these challenges, DL models have the potential to truly innovate the sphere of personalized medicine, especially in terms of neurological therapies.
KW - Blood-brain barrier
KW - Deep learning
KW - Medical technology
KW - Neuroscience
UR - http://www.scopus.com/inward/record.url?scp=105006760004&partnerID=8YFLogxK
U2 - 10.1007/978-1-0716-4474-4_18
DO - 10.1007/978-1-0716-4474-4_18
M3 - Chapter
AN - SCOPUS:105006760004
T3 - Neuromethods
SP - 371
EP - 390
BT - Neuromethods
PB - Humana Press Inc.
ER -